<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The current classification of lymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> is based on clinical information, <z:mp ids='MP_0000002'>morphology</z:mp>, immunophenotype, and molecular genetic characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>Despite technical and scientific progress, some aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with features overlapping between two different types of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> remain difficult to classify </plain></SENT>
<SENT sid="2" pm="."><plain>The updated 2008 World Health Organization (WHO) classification of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumours</z:e> of the Hematopoietic and Lymphoid Tissues has addressed this problem by creation of two new provisional categories of B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, unclassifiable; one with features intermediate between diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and classical Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and the second with features intermediate between diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We review here the diagnostic criteria of these two provisional entities and discuss new scientific findings in light of the 2008 WHO classification </plain></SENT>
</text></document>